Stock

ArriVent BioPharma, Inc. AVBP

$33.67-0.12%

All stocks Create account to unlock

Overview

AVBP market data

Price History

AVBP price chart

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for AVBP. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

4 captured

Truist Securities Maintains Buy on ArriVent BioPharma, Raises Price Target to $45 · May 29, 2026, 4:55 PM

Citigroup Maintains Buy on ArriVent BioPharma, Lowers Price Target to $43 · May 13, 2026, 6:46 PM

8-K filing — ArriVent BioPharma, Inc. (AVBP) · May 11, 2026, 8:43 PM

ArriVent Announces IND Clearance for Novel Tetravalent MUC16/NaPi2b Targeting ADC ARR-002 with Initial Focus in Ovarian and Endometrial Cancers · May 7, 2026, 12:10 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock